Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest PAREXEL International Corporation Stories

2014-04-14 12:32:48

BOSTON, April 14, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the appointment of Peter Steiger, Ph.D., to the newly created position of Vice President and Chief Scientific Officer for Medical Imaging. Dr. Steiger, who has more than 25 years of experience in the application of specialized medical imaging techniques in support of biopharmaceutical product development, will oversee the worldwide...

2014-04-07 08:29:04

BOSTON, April 7, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced Dr. Roland Andersson, Ph.D., and Dr. Thomas Senderovitz, M.D., as Senior Vice Presidents in the Company's Clinical Research Services (CRS) strategic business unit. The executives will be centrally involved in developing and implementing PAREXEL's global corporate objectives. "Roland Andersson and Thomas Senderovitz further strengthen...

2014-03-31 08:28:28

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model BOSTON, March 31, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas, NV. It provides compelling insights that highlight the value of these multi-year, highly integrated...

2014-03-19 08:28:22

Increases global capacity and adds new secondary packaging and labeling services to more efficiently deliver clinical trial supplies BOSTON, March 19, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in...

2014-02-26 08:27:31

BOSTON, Feb. 26, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference in Orlando, FL. James Winschel, Executive Vice President, will be making a presentation on PAREXEL and discussing business developments at 8:05 a.m. ET on Tuesday, March 4, 2014. PAREXEL will also be presenting at the Barclays Capital Healthcare Conference in Miami, FL. James Winschel, Executive Vice President,...

2014-02-19 08:29:50

Company broadens portfolio of regulatory information management solutions to enhance client value BOSTON, Feb. 19, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services in the life sciences industry, with a primary emphasis on post-approval regulatory activities. Through...

2014-02-12 08:28:17

Reflects ongoing commitment to leverage innovation potential between consulting, integrated clinical research and technology-driven services BOSTON, Feb. 12, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL subsidiary that provides the Perceptive MyTrials(®) eClinical platform and other advanced clinical development technology solutions, has been...

2014-02-12 08:28:14

"Your Journey. Our Mission.(TM)" communicates company's new brand promise BOSTON, Feb. 12, 2014 /PRNewswire/ -- As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science...

2014-02-11 08:32:14

Company recognized for providing outstanding work-life balance options for global network of employees BOSTON, Feb. 11, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been named to FlexJobs' list of 100 Top Companies for Remote Jobs in 2014, which recognizes companies for providing the best work-life balance career options through partial and full telecommuting employment...

2014-01-29 16:28:42

-- Increases midpoints of previous revenue and adjusted EPS guidance for FY 2014 BOSTON, Jan. 29, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2014, which ended on December 31, 2013. In commenting on the results of the quarter, Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer, stated, "In the second quarter we met our goals and made progress on...